ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382 | -47.7% | 34,175 | 0.0% | 0.06% | -46.7% |
| Q2 2023 | $731 | -47.1% | 34,175 | 0.0% | 0.12% | -49.4% |
| Q1 2023 | $1,382 | -17.9% | 34,175 | -5.6% | 0.24% | -23.5% |
| Q4 2022 | $1,684 | -99.9% | 36,205 | 0.0% | 0.31% | -17.6% |
| Q3 2022 | $1,878,000 | -17.4% | 36,205 | -24.7% | 0.38% | -13.8% |
| Q2 2022 | $2,274,000 | -40.1% | 48,110 | -9.8% | 0.44% | -33.0% |
| Q1 2022 | $3,798,000 | -33.1% | 53,360 | -29.7% | 0.65% | -31.2% |
| Q4 2021 | $5,673,000 | +59.4% | 75,869 | +21.1% | 0.95% | +43.8% |
| Q3 2021 | $3,558,000 | – | 62,635 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |